LIQUID BIOPSY EGFR TRUE
A liquid biopsy test focused on detecting mutations in the EGFR gene, which are associated with non-small cell lung cancer. It helps in the personalized treatment of lung cancer.
LIQUID BIOPSY EGFR TRUE Test in Guwahati Overview
What is Liquid Biopsy EGFR True test?
Liquid Biopsy EGFR True test analyzes a patient's blood sample to identify genetic mutations in the Epidermal Growth Factor Receptor (EGFR) gene, primarily for non-small cell lung cancer (NSCLC). This test helps determine if a patient's cancer is susceptible to certain tyrosine kinase inhibitor (TKI) drugs, enabling personalized treatment plans and improved patient outcomes. This test identifies mutations in the EGFR gene, which can influence treatment decisions for lung cancer and other tumors
Why consider Liquid Biopsy EGFR True test?
Liquid Biopsy EGFR True test identifies specific genetic changes (EGFR mutations) in tumor cells that predict sensitivity to targeted therapies called EGFR tyrosine kinase inhibitors (TKIs).
- Guides Targeted Therapy
- Personalized Treatment
- Detects Resistance Mutations
Who should get this Liquid Biopsy EGFR True test?
Liquid Biopsy EGFR True test is recommended by clinicians for
- Patients primarily those with newly diagnosed non-small cell lung cancer (NSCLC), especially adenocarcinoma, to determine if their tumor has an EGFR gene mutation
- Patients with advanced NSCLC, especially adenocarcinoma or NSCLC‑NOS with adenocarcinoma features, as part of standard biomarker workup regardless of age, sex, or smoking history.
- Cases with sufficient tumor in FFPE blocks or slides; cytology cell blocks can also be suitable when tissue is limited, per lab validation.
More Information about Liquid Biopsy EGFR True test
EGFR mutation refers to a change in the epidermal growth factor receptor gene that causes continuous activation of its tyrosine kinase signaling, driving tumor growth, most commonly in non‑small cell lung cancer (NSCLC). The two most common mutations are exon 19 deletions and the exon 21 L858R point mutation, together accounting for about 85–90% of EGFR mutations in NSCLC.
Other Names: EGFR Mutation Analysis, EGFR Exon 18–21 Analysis; EGFR Molecular Testing, EGFR mutation test on blood, Liquid biopsy EGFR test
No special preparations needed
- Exon 18 G719x Mutation
- Exon 19 Deletions
- Exon 20 S768i Mutation
- Exon 20 T790m Mutation
- Exon 20 Insertions
- Exon 21 L858r Mutation
- Exon 21 L861q Mutation
Test code
RD1514
Specimen vol. and vacutainer information
| Specimen | Vacutainer | Volume |
|---|---|---|
| Plasma Edta | Lavender Vacutainer |
Specimen stability information
Plasma Edta
Collection instructions
Clinical History
Specimen rejection criteria
Test run frequency
Every Day TIME - 10:00
Turn around time
8 Working Days
Performing locations
Department
- Advanced Molecular Diagnostics R&d
CPT and Loinc codes
Package price
₹15000
Need Help?
Talk to our health experts for guidance on tests, reports, or bookings.
WhatsApp to Book TestLIQUID BIOPSY EGFR TRUE
₹15000